Scientific Program: August 25
Session 5: Precision Imaging / Targeted Therapy
Moderators: B.-I. Choi, R. Garcia Monaco
8:00-8:20 Keynote Lecture 4: MOLECULAR BRAIN IMAGING IN NEURODEGENERATIVE DISEASES: AN EXEMPLAR FOR BIOMARKER DISCOVERY AND CLINICAL TRANSLATION (A. Nordberg)
8:20-8:35 Prostate Cancer Imaging & Treatment: Strategies to enable novel diagnostic and therapeutic techniques to flourish (H. Hricak)
8:35-8:50 Colorectal Tumor Imaging / Treatment: What strategies will enable novel diagnostic and therapeutic techniques to flourish? (R. Beets-Tan)
8:50-9:05 Future Theranostic Applications: Which diseases hold the greatest promise? (J. Lewis)
9:05-9:20 Imaging in the era of liquid biomarkers: How will imaging continue to add value? (M. Mayerhöfer)
9:20-9:35 Network analysis in oncology: How will integration of omics data with imaging biomarkers affect outcomes? (C. Catalano)
9:35-9:50 Integrated diagnostics: How will integration of pathology / laboratory data with imaging affect future diagnostic capabilities? (M. Schnall)
9:50-10:10 Open Discussion
10:10-10:30 Coffee Break
Moderators: B. Hargreaves, G. Langs
10:30-10:45 Targeted therapy with IR: How does IR continue to differentiate and add value, distinct from other minimally invasive targeted therapies? (S. Solomon)
10:45-11:00 Percutaneous Endoscopic Imaging, including Multispectral Imaging: Does this blur the lines with other endoluminal specialties and potentially supplement or replace tissue sampling? (R. Weissleder)
11:00-11:15 Navigational guidance systems for interventions and tumor ablations: How will automation affect the performance of imaged-guided interventional procedures? (R. Uppot)
11:15-11:35 Open Discussion
11:35-12:15 Panel discussion 3: Multidisciplinary Precision Imaging research – Role of academic / industry relationships
Moderators: T. Grist, J. Debatin
Panelists: R. Kubik, A Hartung, A. Spinazzi, C. Herold
12:15-12:35- Open Discussion
12:35-13:25 Lunch
SESSION 6: Environmental, Social, Governance (ESG) Movement
Moderators: A. Norbash, V. Sinitsyn
13:25-13:40 ESG Overview: To what extent should radiology practice embrace ESG concepts? (K. DeStigter)
13:40-13:55 Environmental Impact: What sustainability measures are within reach, and how should equipment manufacturers and radiology departments collaborate to achieve them? (C. Hess)
13:55-14:10 Health Equity – What is the responsibility of radiologists and equipment manufacturers to ensure that imaging care is delivered equitably among the socio-economically disadvantaged? (G. McGinty)
14:10-14:25 Is access to cancer screening uniform among under-resourced environments? (F. Gilbert)
14:25-14:40 Opportunistic Screening – What are the potential benefits and harms of this approach? (P. Pickhardt)
14:40-14:55 Techquity: What impact does access to personal computing and communication devices have on health equity and what steps may be taken to equalize this variable? (B. Jankharia)
14:55-15:15 Open Discussion
15:15-15:35 Coffee Break
Moderators: H. Chandarana, M. Vernooij
15:35-15:50 Closed Loop Follow-Up: How can we keep patients with follow-up recommendations from falling through the cracks? (G. Boland)
15:50-16:05 Leadership Diversity: What benefits come from insuring diversity in our governance structures and how do we ensure our leadership teams are sufficiently diverse? (D. Akata)
16:05-16:45 Panel discussion 4: How should imaging industry and academia respond to the ESG Mandate, and what potential partnerships should be explored?
Moderators: R. Ehman, F. Gallagher
Panelists: M. Fuchsjäger, K. Soyebi, N. Beauchamp, A. Eble, J. Bundy
16:45-17:05 Open Discussion
17:05 Adjourn